THRB and Other metabolic disease: Second, TRβ and liver selective thyromimetics (STRMs) such as GC-1 (sobetirome) and KB2115 (eproterome) have been developed to selectively lower serum cholesterol without deleterious effects on heart and combat other aspects of metabolic disease [12].